Celltrion Group completes first step in developing antiviral treatment to fight COVID-19
Celltrion Group today announced key milestones in its efforts to fight the 2019 novel coronavirus (COVID-19) pandemic. As part of its emergency preparedness plan...
NICE guidelines on active management of patients with COVID-19
The National Institute for Health and Care Excellence (NICE) has published its first three rapid guidelines on the active management of patients with COVID-19...
eyeforpharma Barcelona goes VIRTUAL
Spotlight: Advertorial from Pf Partners
Hi Covid-19 has undoubtedly created one of the most challenging environments of the modern era. Together, we must step up to...
CMA launches COVID-19 taskforce to monitor market practices
The CMA is launching a COVID-19 taskforce to tackle negative impacts within its remit of the coronavirus pandemic. The outbreak of Covid-19 is an unprecedented...
LifeArc launches £10m COVID-19 clinical research fund
LifeArc, a UK-based medical research charity, has created a £10m COVID-19 clinical research fund to support research to accelerate the development and testing of...
Synairgen to start trial of SNG001 in COVID-19
Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...
Study of siltuximab for treating COVID-19 serious respiratory complications initiated
A study of siltuximab for treating COVID-19 serious respiratory complications has been initiated. EUSA Pharma has announced the initiation of the Papa Giovanni XXIII Hospital...
First coronavirus vaccine clinical trial starts
The first coronavirus vaccine clinical trial has started at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The Phase 1 clinical trial is...
FDA emergency authorisation for Roche’s COVID-19 test
Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
Elsevier gives full access to its coronavirus information centre content
Elsevier is giving full access to its content on its coronavirus information centre for PubMed Central and other public health databases, such as the...
Latest articles
APM study reveals the contribution of project management in pharma and life science
A study by the Association for Project Management has revealed the contribution of projects and project management in pharma and life sciences. Rebecca Fox, Head...
Medicago begins Phase I clinical trials for its COVID-19 vaccine candidate
Medicago, a biopharmaceutical company headquartered in Quebec City, has started Phase I clinical trials for its plant-derived COVID-19 vaccine candidate, administering the first doses...
Becoming a leading pharma company in the new normal
The pharma supply chain has been stress tested to breaking point in the past few months. Many life science companies have transitioned to entirely...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
COVID-19: A Catalyst for Change in Government-Industry Partnership
How outsourced pharma healthcare workers are supporting the Office for National Statistics COVID-19 Infection Survey as part of a Government-industry partnership. COVID-19 has seen the...
Becoming a leading pharma company in the new normal
The pharma supply chain has been stress tested to breaking point in the past few months. Many life science companies have transitioned to entirely...
Innovative technology in the medical devices market
Bernard Ross explores innovative technology in the medical devices market especially relating to venous thromboembolism (VTE). According to Cordant Recruitment, the global medical devices market...
Market Access in practice: do you have a strategy?
This article is a little old... but if you're interested in Market Access we have plenty of new content: July 2018 Market Access Special Edition...